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Both the homing of hematopoietic stem cells (HSCs) to the
bone marrow and their engraftment in recipients of bone
marrow transplants are primarily mediated by the chemokine
stromal-derived factor-1 (SDF-1) or CXCL12, which activates
CXCR4, its cognate receptor on HSCs. We showed that the
recruitment and temporary attachment of CXCR4-expressing
cells, such as HSCs and a fraction of mesenchymal stem cells
(MSCs), to the kidney, following ischemia/reperfusion acute
kidney injury, are similarly mediated by robustly upregulated
SDF-1 in the kidney, indicating that such organ injury
appears to lead to the transient expression of a facultative
stem cell niche. This SDF-1 response of the injured kidney
facilitates both the mobilization from the bone marrow and
homing of precursor cells, and other CXCR4-expressing cells
such as administered MSCs, to the kidney, where they aid
in its protection and repair. Similar responses have been
observed subsequent to the injury of other solid organs
such as the heart, liver, and brain.
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During the last few years, preclinical stem cell research has
reached the stage where the feasibility, safety, and efficacy of
stem cell therapy for numerous treatment-resistant disorders
are being tested in clinical trials. Testing and use of this
fundamentally new and promising therapeutic principle not
only requires knowledge of the mediator mechanisms
whereby these cells function, but also an understanding
regarding their trafficking, extravasation, homing, and
migration to organs after their administration, and the
factors involved in the regulation of these critical processes
(Figure 1). The involvement and importance of stromal-
derived factor-1 (SDF-1) for homing of hematopoietic stem
cells to the bone marrow after hematopoietic stem cell
transplantation, the first successful application of stem cell
therapy in the clinic, is well established.
Acute kidney injury (AKI) is a common and potentially
fatal clinical problem, and its therapy is limited to supportive
measures. Experimental animal studies have provided data
showing that stem cell therapies have the potential to provide
a completely new and promising treatment principle for AKI.
This following review is intended to provide relevant details
regarding the importance of SDF-1 as a stem cell regulatory
factor in AKI.
FUNCTION AND SIGNIFICANCE OF SDF-1
SDF-1 belongs to a complex group of chemokines, which are
small molecules involved in the regulation of inflammation
and migration of cells.1 There are more than 50 different
chemokines and more than 20 receptors that have been
cloned. There frequently exists significant promiscuity in the
binding of several of these chemokines to multiple receptors,
albeit with variable affinity and different responses. SDF-1 is
unique in this regard as it only binds to its principal receptor,
termed CXCR4, and to a recently identified second receptor
CXCR7.2,3 SDF-1 and CXCR4 are also unique with regard to
their importance for embryonic development, with knockout
of either one resulting in fetal lethality. The SDF-1/CXCR4
axis regulates trafficking of stem cells during development, in
homeostasis, inflammation, and in regeneration. Intracellular
signaling of SDF-1 via CXCR4 occurs via G-protein-activated
downstream pathways, which includes ras, phosphatidylino-
sitol 30-kinase, Janus kinase/signal transducers and activators
of transcription signaling, activation of transcription factors,
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as well as linkage to the cytoskeletal system that promotes
cell migration.4 The major biological effects of SDF-1 include
the induction of motility, chemotactic responses, cell
adhesion, and increased adhesion to vascular cellular adhe-
sion molecule-1, intercellular adhesion molecule-1, and
fibrinogen, induction of metalloproteinases and angiopoietic
factors, as well as proliferation and cell survival. SDF-1 and
CXCR4 expressions are regulated by transcription factors
including hypoxia-inducible factor-1a and nuclear factor-
kB.5 Hypoxia-inducible factor-1a stabilization leads to
upregulation of SDF-1 through binding to promoter sites,
whereas the von Hippel-Lindau protein negatively regulates
SDF-1 expression. SDF-1 has been shown to be upregulated
in myocardial infarction, limb ischemia, toxic liver damage,
excessive bleeding, total body irradiation, and tissue damage
related to chemotherapy.6
SDF-1/CXCR4 AND STEM CELLS
CXCR4 is expressed on hematopoietic stem cells, endothelial
progenitor cells, neural stem cells, primordial germ cells,
liver oval cells, skeletal muscle satellite cells, embryonic stem
cells, and cancer stem cells.4 It is furthermore expressed on
subgroups of neutrophiles, monocytes, B cells, and T cells.
Accordingly, CXCR4 is one of the major receptors that
regulates trafficking of hematopoietic stem cells and
progenitor cells. Furthermore, CXCR4 is involved in the
regulation of angiogenesis, in part through recruitment of
endothelial progenitor cells, and is important in trafficking of
tissue stem cells, as well as guiding CXCR4-positive cells
during embryogenesis, development, and tissue regeneration.
In cancer, CXCR4 regulates locomotion of metastatic cells
and is involved in tumor angiogenesis. Knockout of CXCR4
results in death in utero due to hematopoietic and cardiac
defects, as well as changes in brain development.7
The SDF-1/CXCR4 axis facilitates tumor cells access to
cellular niches such as those in the bone marrow, where it
mediates survival and directly stimulates growth of neoplastic
cells in a paracrine manner.8 SDF-1 has been shown to be a
prognostic marker in acute myelogenous leukemia and in
breast cancer, and it is involved in the establishment of the
cancer stem-like cell niche.
CXCR4/SDF-1 IN THE KIDNEY
There is limited knowledge regarding the involvement of the
SDF-1/CXCR4 axis in the development and homeostasis of
the normal kidney, although one report showed SDF-1
expression in the developing kidney.9 Therefore, our group
investigated the expression pattern and functions of the SDF-
1/CXCR4 system in the normal kidney, as well as after
ischemia/reperfusion-induced AKI.10 SDF-1 is expressed in
the normal kidney mostly by distal tubular cells in the cortex,
as determined by in situ hybridization, immunohisto-
chemistry, and enzyme-linked immunosorbent assay. CXCR4
expression in the kidney is of similar distribution to that of
SDF-1. Within 24 h of induction of ischemia/reperfusion
AKI, all kidney regions show robust expression of SDF-1 and
CXCR4, indicating significant, injury-induced upregulation
of both. This was demonstrated using real-time quantitative
reverse transcriptase-polymerase chain reaction and enzyme-
linked immunosorbent assay. In vitro studies with adenosine 50
triphosphate depletion of primary, proximal tubular kidney
cells in culture showed upregulation of SDF-1 mRNA as early
as 90min after chemically induced ‘hypoxia’. In vitro and
in vivo migration and homing assays demonstrated the
importance of the SDF-1/CXCR4 axis in cell migration toward
injured kidney cells, which was abrogated by neutralizing anti-
CXCR4 antibodies. Systemically, we demonstrated a reversal
of the physiological bone marrow–plasma SDF-1 gradient,
characterized after AKI by plasma levels of SDF-1 that
significantly exceeded those present in the bone marrow. This
chemokine pattern resulted in the mobilization, from the bone
marrow, of CXCR4-expressing progenitor cells into circulation
and their recruitment into the injured kidney.
In summary, our data show that renal SDF-1 is an
important mediator of homing and migration of CXCR4-
positive cells toward the injured kidney. Furthermore, these
data indicate that SDF-1 is a major factor involved in kidney
repair through recruitment of cells involved in regeneration,
including endothelial progenitor cells, as well as administered
stem and other progenitor cells.
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Figure 1 | Injury-induced upregulation of stromal-derived
factor-1 (SDF-1) in major organs results in mobilization,
from the bone marrow, and recruitment of stem cells
expressing CXCR4 (SDF-1 receptor).
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